Real vaccines in the real world: Tuberculosis vaccines move south

Expert Review of Vaccines

Volumn 7, Issue 6, 2008, Pages 703-707

  Dockrell, Hazel M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD40 LIGAND; GAMMA INTERFERON; INTERLEUKIN 2; TUBERCULIN;

BCG VACCINATION; EDITORIAL; ENVIRONMENTAL EXPLOITATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HOST RESISTANCE; HUMAN; INFECTION RISK; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; SEASONAL VARIATION; TUBERCULOSIS; VACCINE PRODUCTION;

HUMANS; MYCOBACTERIUM; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 49449101801     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.7.6.703     Document Type: Editorial

References (40)

1. Sander C, McShane H. Translational mini-review series on vaccines: development and evaluation of improved vaccines against tuberculosis. Clin. Exp. Immunol. 147, 401-411 (2007).
2. Reece ST, Kaufmann SH. Rational design of vaccines against tuberculosis directed by basic immunology. Int. J. Med. Microbiol. 298, 143-150 (2008).
3. Reed MB, Domenech P, Manca C et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431, 84-87 (2004).
4. Caws M, Thwaites G, Dunstan S et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 4, e1000034 (2008).
5. Portaels F, Meyers WM, Ablordey A et al. First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl. Trop. Dis. 2, e178 (2008).
6. Wayne LG, Sramek HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin. Microbiol. Rev. 5, 1-25 (1992)
7. Chilima BZ, Clark IM, Floyd S, Fine PE, Hirsch PR. Distribution of environmental mycobacteria in Karonga District, northern Malawi. Appl. Environ. Microbiol. 72, 2343-2350 (2006).
8. September SM, Brozel VS, Venter SN. Diversity of non-tuberculoid mycobacterium species in biofilms of urban and semiurban drinking water distribution systems. Appl. Environ. Microbiol. 70, 7571-7573 (2004).
9. Hatherill M, Hawkridge T, Whitelaw A et al. Isolation of non-tuberculous mycobacteria in children investigated for pulmonary tuberculosis. PLoS ONE 1, e21 (2006).
10. Martin-Casabona N, Bahrmand AR, Bennedsen J et al. Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int. J. Tuberc. Lung Dis. 8, 1186-1193 (2004).
11. Yates MD, Pozniak A, Uttley AH, Clarke R, Grange JM. Isolation of environmental mycobacteria from clinical specimens in south-east England: 1973-1993. Int. J. Tuberc. Lung Dis. 1, 75-80 (1997).
12. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect. Immun. 64, 16-22 (1996).
13. Andersen P, Doherty TM. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3, 656-662 (2005)
14. Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am. Rev. Respir. Dis. 99(Suppl. 4), 1-132 (1969).
15. Edwards LB, Acquaviva FA, Livesay VT. Identification of tuberculous infected. Dual tests and density of reaction. Am. Rev. Respir. Dis. 108, 1334-1339 (1973).
16. Palmer CE, Long MW. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am. Rev. Respir. Dis. 94, 553-568 (1966).
17. Brandt L, Feino Cunha J, Weinreich Olsen A et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70, 672-678 (2002).
18. Buddle BM, Wards BJ, Aldwell FE, Collins DM, de Lisle GW. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 20, 1126-1133 (2002).
19. Demangel C, Garnier T, Rosenkrands I, Cole ST. Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens. Infect. Immun. 73, 2190-2196 (2005).
20. Ponnighaus JM, Fine PE, Sterne JA et al. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet 339, 636-639 (1992).
21. Black GF, Weir RE, Floyd S et al. BCG-induced increase in interferon-γ response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359, 1393-1401 (2002).
22. Black GF, Dockrell HM, Crampin AC et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J. Infect. Dis. 184, 322-329 (2001).
23. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346, 1339-1345 (1995).
24. Weir RE, Black GF, Nazareth B et al. The influence of previous exposure to environmental mycobacteria on the interferon-γ response to bacille Calmette-Guérin vaccination in southern England and northern Malawi. Clin. Exp. Immunol. 146, 390-399 (2006).
25. Young SL, Slobbe L, Wilson R, Buddle BM, de Lisle GW, Buchan GS. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination. Infect. Immun. 75, 2833-2840 (2007).
26. Flaherty DK, Vesosky B, Beamer GL, Stromberg P, Turner J. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. J. Leukoc. Biol. 80, 1262-1271 (2006).
27. Moore SE, Collinson AC, Tamba N'Gom P, Aspinall R, Prentice AM. Early immunological development and mortality from infectious disease in later life. Proc. Nutr. Soc. 65, 311-318 (2006).
28. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol. 37, 113-119 (2008).
29. Moore SE, Collinson AC, Fulford AJ et al. Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan. Trop. Med. Int. Health 11, 1529-1541 (2006).
30. Miles DJ, van der Sande M, Crozier S et al. Effect of antenatal and postnatal environment on CD4 T-cell responses to BCG in healthy Gambian infants. Clin. Vaccine Immunol. 15(6), 995-1002 (2008).
31. Collinson AC, Moore SE, Cole TJ, Prentice AM. Birth season and environmental influences on patterns of thymic growth in rural Gambian infants. Acta Paediatr. 92, 1014-1020 (2003).
32. Ngom PT, Collinson AC, Pido-Lopez J, Henson SM, Prentice AM, Aspinall R. Improved thymic function in exclusively breastfed infants is associated with higher interleukin 7 concentrations in their mothers' breast milk. Am. J. Clin. Nutr. 80, 722-728 (2004).
33. + T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clin. Exp. Immunol. 132, 113-119 (2003).
34. Messele T, Abdulkadir M, Fontanet AL et al. Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin. Exp. Immunol. 115, 443-450 (1999).
35. Wild CP. Aflatoxin exposure in developing countries: the critical interface of agriculture and health. Food Nutr. Bull. 28(Suppl. 2), S372-S380 (2007).
36. Hetherington SV, Lepow ML. Correlation between antibody affinity and serum bactericidal activity in infants. J. Infect. Dis. 165, 753-756 (1992).
37. Heath PT. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Pediatr. Infect. Dis. J. 17(Suppl. 9), S117-S122 (1998).
38. Lee YC, Newport MJ, Goetghebuer T et al. Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins. Vaccine 24, 5335-5340 (2006).
39. Marchant A, Pihlgren M, Goetghebuer T et al. Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infants. J. Infect. Dis. 193, 1598-1605 (2006).
40. Newport MJ, Goetghebuer T, Weiss HA, Whittle H, Siegrist CA, Marchant A. Genetic regulation of immune responses to vaccines in early life. Genes Immun. 5, 122-129 (2004).